NCT05877677

Brief Summary

To assess the efficacy of polygonatum kingianum extract on endurance performance and anti-fatigue

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 17, 2023

Completed
1 day until next milestone

Study Start

First participant enrolled

May 18, 2023

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 26, 2023

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 17, 2023

Completed
14 days until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2023

Completed
Last Updated

August 8, 2023

Status Verified

August 1, 2023

Enrollment Period

1 month

First QC Date

May 17, 2023

Last Update Submit

August 4, 2023

Conditions

Outcome Measures

Primary Outcomes (4)

  • The change of aerobic endurance

    3-min step test is used to assess aerobic endurance

    Day 0, day 14, day28

  • The change of continuous attention performance

    Canon continuous attention software (Conners' Continuous Performance Test) is used to assess continuous attention performance

    Day 0, day 14, day28

  • The change of concentration of testosterone in blood

    Fasting venous blood was sampled to measure concentrations of testosterone

    Day 0, day 14, day28

  • The change of blood PDE5 gene expression

    Fasting venous blood was sampled to measure the expression of PDE5 gene

    Day 0, day 14, day28

Secondary Outcomes (2)

  • The change of blood nitric oxide (NO)

    Day 0, day 14, day28

  • The change of self-assessment fatigue condition

    Day 0, day 14, day28

Other Outcomes (3)

  • The change of concentrations of liver function biomarkers (AST, ALT) in blood

    Day 0, day 14, day28

  • The change of concentrations of renal function biomarkers (BUN, creatinine) in blood

    Day 0, day 14, day28

  • The change of concentrations of blood lipid profiles (total cholesterol, LDL-C, HDL-C, triglyceride)

    Day 0, day 14, day28

Study Arms (2)

Placebo drink

PLACEBO COMPARATOR

consume 1 bottle per day

Dietary Supplement: Placebo drink

Polygonatum kingianum extract drink

EXPERIMENTAL

consume 1 bottle per day

Dietary Supplement: Polygonatum kingianum extract drink

Interventions

Placebo drinkDIETARY_SUPPLEMENT

consume 1 bottle per day

Placebo drink

consume 1 bottle per day

Also known as: Dragon Power® Polygonatum kingianum extract drink
Polygonatum kingianum extract drink

Eligibility Criteria

Age30 Years - 60 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Healthy male aged 30-60 years old
  • Must read and sign the informed consent form
  • During the experiment, do not change the lifestyle and eating habits
  • Cooperate not to engage in high-intensity exercise 48 hours before each experiment

You may not qualify if:

  • Subject who is not willing to participate in this study.
  • People with serious diseases of heart, liver, kidney, endocrine and other organs (such as hypertension, diabetes, renal dysfunction and heart-related diseases) and mental patients
  • People who have undergone surgery within 6 months or have lower limb injuries
  • People who are allergic to Polygonatum kingianum extract
  • Participate in other clinical trials related to anti-fatigue within four weeks of the trial
  • Students who are currently taking courses taught by the principal investigator of this trial.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Pingtung University of Science and Technology

Pingtung City, Taiwan

Location

MeSH Terms

Conditions

Fatigue

Condition Hierarchy (Ancestors)

Signs and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Bo-han Wu

    National Pingtung University of Science and Technology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 17, 2023

First Posted

May 26, 2023

Study Start

May 18, 2023

Primary Completion

June 17, 2023

Study Completion

July 1, 2023

Last Updated

August 8, 2023

Record last verified: 2023-08

Locations